Valley retina Institute

McAllen, Texas 78504

3 studies enrolling now · 50 studies all time

What they study most

AMD, Age Related Macular Degeneration, Age Related Macular Degeneration (ARMD), Age-Related Macular Degeneration, Cataracts, Central Serous Retinopathy, Choroidal Neovascularization, Clear Lens Exchange, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Diffuse Diabetic Macular Edema

Studies at this site

• A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — Recruiting now
• Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID) — Recruiting now
• A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration — Recruiting now
• A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa — Running, not enrolling
• Expanded Access Program for RP in Adults — NO_LONGER_AVAILABLE
• Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — Running, not enrolling
• A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease — Running, not enrolling
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
• Long-Term Safety Study of Tafenoquine — Completed
• Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial — Running, not enrolling
• Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD — Completed
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• A Single Ascending Dose Cohort Study of AG-73305 in DME Patients — Completed
• A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products — Completed
• Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) — Running, not enrolling
• Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion — Completed
• Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION) — Completed
• The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME) — Completed
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
• LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye — Stopped early
• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration — Completed
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — Completed
• Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration — Completed
• Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
• A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration — Stopped early
• Post-Approval Study of the Implantable Miniature Telescope — Enrolling by invitation
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
• A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy — Completed
• Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results — Status unconfirmed
• Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO — Completed
• Study of Topical Ocular PAN-90806 in PDR — Completed
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
• Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control — Completed
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
• Ocriplasmin Research to Better Inform Treatment (ORBIT) — Completed
• PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) — Completed
• Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion — Completed
• Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema — Completed
• A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD — Completed